Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia
Year: 1986
Type: article
Study design: Clinical Trial
Source: The American Journal of Medicine
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
Award: G1042671589
OpenAlex ID: W2012891007
